Back Pain Doctor
Morton Neuroma and Forefoot Pain
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Morton neuroma describes irritation and thickening around a nerve between the metatarsal bones in the forefoot. Intermetatarsal bursitis can produce similar symptoms and may coexist. Patients often describe burning, tingling, numbness or a feeling of walking on a small pebble.
Assessment considers footwear, foot shape, activity load, tenderness between the metatarsals and whether symptoms are nerve-like. Ultrasound can be useful when the diagnosis is uncertain or an image-guided procedure is being planned.
Non-surgical care usually begins with reducing compression through the forefoot. This may involve wider shoes, metatarsal support, load modification and addressing training or work demands. Persistent symptoms may warrant discussion of injection options and, in selected cases, surgical referral.
Common symptoms
- Burning, tingling or numbness into the toes
- Pain under the ball of the foot
- Feeling like there is a pebble or fold in the sock
- Symptoms worse in narrow shoes, heels or prolonged walking
Commonly seen in
Evidence for twelve treatment options in morton neuroma and forefoot pain
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Conservative care comes first, and it holds up well. A network meta-analysis of 49 randomised trials and 3,323 patients with carpal tunnel syndrome ranked manual therapy first for both short- and medium-term pain relief, ahead of every injection option including corticosteroid (Chen, Arch Phys Med Rehabil 2025).
Pairing reviewed 2026-09-02.
Where it fits
Load management, splinting where it fits, and addressing what is irritating the nerve come before any injection. Where the nerve is being compressed structurally and function is being lost, surgical review is the right conversation rather than more conservative care.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
No study has tested trigger point needling or injection in Morton's neuroma. A search pairing dry needling, trigger point needling and needling with Morton's, interdigital and intermetatarsal neuroma returned one relevant record, a technical note describing repeated ultrasound-guided needle punctures to break up the fibrous tissue around the nerve between the metatarsal heads, without trial outcomes (Atilano, Muscles Ligaments Tendons J 2016). That is a different procedure aimed at the scar tissue around the nerve, not at a muscle band.
Pairing reviewed 2026-10-01.
Where it fits
Rarely relevant. The pain comes from the nerve between the toes rather than a muscle band, so this is considered only where a separate tender muscle in the foot or calf is adding to it.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Good support
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
This is one of the few places where ultrasound guidance was compared head to head with an unguided injection. In an evaluator-blinded randomised trial, 33 people had landmark-guided corticosteroid injection and 38 had it under ultrasound; pain improvement favoured the guided group out to three years, and satisfaction at three years was 87 per cent against 59 per cent (Santiago, Eur Radiol 2022). A systematic review of ten studies in 695 people found a moderate short- to medium-term benefit over usual care with a low rate of adverse events, though it rated study quality low (Edwards, J Am Podiatr Med Assoc 2021). Expectations should be set against the ceiling: pooling 2,998 patients, complete pain relief followed injection in 43 per cent (95% CI 23 to 64) against 74 per cent (66 to 82) after surgical excision, and 15 per cent of injected patients went on to surgery (Lu, Acta Neurochir 2020).
Pairing reviewed 2026-09-10.
Where it fits
A reasonable first step before considering surgery, with footwear and forefoot loading addressed alongside. Repeated corticosteroid into the web space is not the plan: see the note on cortisone.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Two small sham trials; pooled null
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched again 17 October 2026 (14 records, all read). Unlike the other entrapments, the neuroma itself has been trialled, but the work is small, contested, and neither trial says whether a radial or a focused device was used. In 25 feet after more than eight months of failed conservative care, pain fell significantly after shockwave and not after sham over twelve weeks, but each group was compared only with its own starting point (Fridman, J Am Podiatr Med Assoc 2009); that result drew three published letters questioning its analysis and reporting (Payne; Turlik; Landorf, J Am Podiatr Med Assoc 2009). A second sham-controlled trial found the same pattern over four weeks, with no change in satisfaction or in neuroma size on ultrasound (Seok, J Am Podiatr Med Assoc 2016). Pooled, the shockwave trials did not differ significantly from control (pain -5.9 points out of 100, 95% CI -21.9 to 10.1) (Matthews, J Foot Ankle Res 2019). A systematic review of 22 studies of non-operative treatment found shockwave produced a statistically significant improvement but with limits on where it applies, and recommended corticosteroid injection ahead of it (Thomson, Foot Ankle Surg 2019). A review of common foot and ankle conditions lists activity modification, orthoses and interdigital corticosteroid injection as first-line here and does not include shockwave (Cooper, JAMA 2023).
Pairing reviewed 2026-10-17.
Where it fits
The neuroma lies shallow enough for a radial device to reach it, so it is not implausible, but corticosteroid injection is the better-evidenced option and comes first. Worth raising only once injection has been tried or declined.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Two small sham trials; pooled null
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Searched 17 October 2026: shockwave, shock wave or ESWT with Morton's, interdigital, intermetatarsal or plantar digital neuroma (14 records, all read), plus a systematic-review and randomised-trial pass across nerve entrapments. Two small randomised trials against sham, neither stating whether the device was focused or radial. In 25 feet after more than eight months of failed care, pain fell after shockwave and not after sham over twelve weeks, but each group was compared only with its own starting point, not with the other (Fridman, J Am Podiatr Med Assoc 2009), and three letters in the same journal criticised the analysis and reporting (Payne; Turlik; Landorf, J Am Podiatr Med Assoc 2009). A second sham trial found the same pattern over four weeks, with no change in satisfaction or in the size of the neuroma on ultrasound (Seok, J Am Podiatr Med Assoc 2016). When the shockwave trials were pooled, the difference from control was not significant (pain -5.9 points out of 100, 95% CI -21.9 to 10.1) (Matthews, J Foot Ankle Res 2019), and a review of 22 studies recommended corticosteroid injection ahead of shockwave (Thomson, Foot Ankle Surg 2019).
Pairing reviewed 2026-10-17.
Where it fits
Footwear, a metatarsal pad and a corticosteroid injection come first. Shockwave can be raised once those have been tried or declined, with the message that the two small trials and the pooled analysis do not agree.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Not offered; one unblinded trial
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Trialled once in a Morton neuroma, with a result that favours PRP, and not offered here. Sixty people with a Morton neuroma confirmed on examination and MRI, all of whom had already had at least six months of conservative treatment without success, were randomised to three injections of PRP or a single cortisone injection. Both groups improved, and PRP scored better at three, six and twelve months: at twelve months physical function was 61.8 against 55.2 (higher is better) and pain interference 38.4 against 44.2 (lower is better) on the PROMIS scales, and at six months the neuroma measured 4.2 mm against 5.8 mm on MRI. Complications were few in both groups (Genuth, Foot Ankle Int 2026). The limits are plain: nobody was blinded, the PRP group had three injections to the cortisone group's one, there was no dummy-injection group, and the authors themselves call the result hypothesis-generating until a larger and more rigorous trial repeats it. The only other report is a single case in which pain fell from 9 to 1 out of 10 at twelve months after two injections (Hehsan, Pain Med Case Rep 2026). A JAMA review lists a cortisone injection among the first-line treatments and notes that about three in ten people do not respond to conservative treatment (Cooper, JAMA 2023), and a European radiology consensus puts ultrasound-guided cortisone at its highest level of evidence for this condition (Sconfienza, Eur Radiol 2021).
Pairing reviewed 2026-10-11.
Where it fits
Not offered here for a Morton neuroma. Footwear changes, a metatarsal pad or orthotic and, where needed, an ultrasound-guided cortisone injection are the treatments with the strongest evidence, with a surgical opinion where those have not been enough. The single PRP trial is unblinded and has not been repeated.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Not offered for this
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
A search for dextrose or prolotherapy in Morton's and interdigital neuroma returned 11 records, and not one was a trial of either. One was about fungal infection between the toes cultured on dextrose agar. A review of injection treatment for chronic foot pain covers steroid, alcohol, capsaicin and hyaluronic acid for Morton's neuroma and does not include prolotherapy (Urits, Pain Ther 2020).
Pairing reviewed 2026-09-03.
Where it fits
Not offered for this. A Morton's neuroma is a thickened nerve between the toes, and the useful first steps are footwear width, a metatarsal dome and offloading rather than an injection aimed at ligament.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used here
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Trialled at this nerve, but not offered here. Forty-four people with 48 affected feet were randomised to three weekly ultrasound-guided injections of either hyaluronic acid or triamcinolone: both groups improved in pain and AOFAS score out to twelve months, cortisone was clearly ahead at one, three and six months, and the two were no different by twelve. A quarter of the cortisone feet developed skin discolouration at the injection site while the hyaluronic acid group had no complications, and nobody in either group went on to have the neuroma removed (Ferreira, Bone Joint J 2024). A separate series of 83 people given the same three-injection course saw walking pain fall from 73 to 23 out of 100 and AOFAS rise from 32 to 87 at twelve months (Lee, Foot Ankle Int 2017). A systematic review of twelve injection studies in 1,438 people rates hyaluronic acid well tolerated but still under-researched (Millán-Silva, Pain Manag Nurs 2024). There is no placebo-controlled trial.
Pairing reviewed 2026-10-05.
Where it fits
Not offered for this problem. Hyaluronic acid is considered only for a problem inside a joint, and a Morton's neuroma is a nerve problem.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Plausible: no studies
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Searched 29 October 2026: Morton's, interdigital or intermetatarsal neuroma with dextrose, glucose, prolotherapy, perineural injection, neural prolotherapy, hydrodissection or hydrorelease (13 records); the neuroma with any injection and dextrose, saline, anaesthetic, hyaluronic acid or perineural terms (45); and randomised-trial (18) and systematic-review (24) passes. All were read. No study of any design has tested dilute dextrose injected under the skin or around the nerve for a Morton neuroma. The injection trials at this nerve are of other injectates: a Cochrane review of six trials (373 people) found cortisone with local anaesthetic did not clearly beat local anaesthetic alone on pain (-6.3 points out of 100, 95% CI -14.2 to 1.6, low certainty), and that ultrasound guidance improved the result of the same injection (-15.0, -27.9 to -2.1) (Matthews, Cochrane Database Syst Rev 2024); capsaicin injected into the web space beat placebo at one and four weeks in 58 people (Campbell, Pain 2016). The dextrose trials behind this treatment are at the median nerve in the carpal tunnel, a different nerve.
Pairing reviewed 2026-10-29.
Where it fits
Considered only where footwear changes, a metatarsal pad and an ultrasound-guided cortisone injection have not settled the neuroma and surgery is being avoided, with the plain statement that it has not been studied at this nerve.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Plausible: no studies
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Searched 29 October 2026: Morton's, interdigital or intermetatarsal neuroma with dextrose, glucose, prolotherapy, perineural injection, neural prolotherapy, hydrodissection or hydrorelease (13 records); the neuroma with any injection and dextrose, saline, anaesthetic, hyaluronic acid or perineural terms (45); and randomised-trial (18) and systematic-review (24) passes. All were read. No study has tested hydrodissection as a treatment for a Morton neuroma. The only hydrodissection record at this nerve describes fluid used during open surgery to help remove the neuroma, with no clinical outcome reported (Faridi, Foot Ankle Orthop 2024). The nearest evidence is for a smaller-volume cortisone injection beside the nerve, and it is itself mixed: in 131 people, ultrasound-guided methylprednisolone with lignocaine beat lignocaine alone at three months (14.1 points on a 100-point foot health scale, 95% CI 5.5 to 22.8) (Thomson, J Bone Joint Surg Am 2013), a double-blind trial of 41 found no difference from local anaesthetic at three or six months (Lizano-Díez, Foot Ankle Int 2017), and the Cochrane review pooling these trials found no clear difference (Matthews, Cochrane Database Syst Rev 2024). Those are cortisone trials, not hydrodissection.
Pairing reviewed 2026-10-29.
Where it fits
Considered where a Morton neuroma has not settled with footwear, padding and a cortisone injection and surgery is being avoided, with the absence of any study of hydrodissection at this nerve explained.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other foot, ankle & lower leg conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Is Morton neuroma actually a tumour?
What helps forefoot nerve pain?
Is imaging useful?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment